Related Experiment Video
Updated: Jul 6, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
All-cause mortality in insulin-treated diabetic patients: a 20-year follow-up
Shelagh I Dawson1, Jinny Willis, Christopher M Florkowski
1Centre for Postgraduate Nursing Studies, Christchurch School of Medicine, University of Otago, New Zealand. shelagh.dawson@otago.ac.nz
Aims:
To establish all-cause mortality rates, and risk factors for mortality in insulin-treated diabetic individuals living in Canterbury, New Zealand.
Methods:
Insulin-treated diabetic subjects (n=995) on the Canterbury Diabetes Registry were followed up over 20-year and vital status determined. Death rates were standardised and hazard regression was used to model the effects of demographic covariates on relative survival time.
Results:
Six subjects had emigrated, the remaining 989 diabetic subjects contributed a total of 13705.53 person-years of follow-up, a mean of 13.7 years per subject. During follow-up 525 deaths occurred in subjects' aged 17.3-96.7, (261 females, 264 males). All-cause mortality rates in diabetic subjects exceeded those in the general population at all ages. SMRs were slightly higher for females than males in almost all age-at-onset groups, being 2.48 (95% CI: 2.18-2.78) for females and 2.17 (95% CI: 1.91-2.43) for males overall, but reaching a peak in the <30 age at onset group for both females and males being 4.25 (3.07-5.44) and 3.26 (2.49-4.03), respectively.
Conclusions:
Mortality rates for diabetic individuals remain high, resulting in shortened life spans relative to the general population. This study provides a baseline for further studies of mortality and changes in mortality within New Zealand.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Complications of Diabetes Mellitus
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
